1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Virus-like Particles Market – By Product Type

1.3.2        Europe Virus-like Particles Market – By Source

1.3.3        Europe Virus-like Particles Market – By Application

1.3.4        Europe Virus-like Particles Market – By Country

2.           Europe Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Europe Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Raising Prevalence of Infectious Viral Diseases

5.1.2        The Growing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Access of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Boosting Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Ongoing Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           Europe Virus-like Particles Market Analysis

6.1         Europe Virus-like Particles Market Revenue Forecast and Analysis

7.           Europe Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         Europe Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           Europe Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         Europe Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           Europe Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         Europe Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        Europe Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     Europe: Virus-like Particles Market, by Country, 2021 & 2028(%)

10.1.1.1       Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.5       Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.5       France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5       UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4       Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5       Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5       Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4       Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5       Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6       Rest of Europe: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4       Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5       Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Europe Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        Europe Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Dynavax Technologies

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sanofi

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Serum Institute of India Pvt. Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      BHARAT BIOTECH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      LG Chem

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 7.             France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 10.          UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14.          Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 16.          Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20.          Organic Developments Done by Companies

Table 21.          Inorganic Developments Done by Companies

Table 22.          Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1.           Europe Virus-like particles Market Segmentation

Figure 2.           Europe Virus-like particles Market Segmentation, By Country

Figure 3.           Europe Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in Europe Virus-like particles Market

Figure 5.           The UK to Show Significant Growth during Forecast Period

Figure 6.           Europe Virus-like Particles Market, Industry Landscape

Figure 7.           Europe PEST Analysis

Figure 8.           Europe Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           Europe Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        Europe Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Europe Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Europe: Virus-like Particles Market, by Key Country – Revenue (2021) (USD Million)

Figure 23.        Europe: Virus-like Particles Market, by Country, 2021 & 2028 (%)

Figure 24.        Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in European Country Markets